Evidence map›Paper›PMID 35414170›Full record

ReviewAccounts of chemical research2022

Water-Soluble Tris(cyclometalated) Iridium(III) Complexes for Aqueous Electron and Energy Transfer Photochemistry.

Mirjam R Schreier, Xingwei Guo, Björn Pfund, Yasunori Okamoto, Thomas R Ward, Christoph Kerzig, Oliver S Wenger

Open access · hybridAbstract readReview
In one paragraph

Review in Accounts of chemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 76 citations in OpenAlex.

  1. Isomorphous dinuclear copper(I) complexes bridged by 4-methyl-1Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Luminescence and Palladium: The Odd Couple.Molecules (Basel, Switzerland) · 2023
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mirjam R SchreierDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056 Basel, Switzerland.
Xingwei GuoDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056 Basel, Switzerland.ORCID 0000-0002-5461-0360
Björn PfundDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056 Basel, Switzerland.
Yasunori OkamotoNational Competence Center in Research, Molecular Systems Engineering, 4002 Basel, Switzerland.ORCID 0000-0002-2442-6079
Thomas R WardNational Competence Center in Research, Molecular Systems Engineering, 4002 Basel, Switzerland.ORCID 0000-0001-8602-5468
Christoph KerzigDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056 Basel, Switzerland.ORCID 0000-0002-1026-1146
Oliver S WengerDepartment of Chemistry, University of Basel, St. Johanns-Ring 19, 4056 Basel, Switzerland.ORCID 0000-0002-0739-0553
University of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclometalated iridium(III) complexes are frequently employed in organic light emitting diodes, and they are popular photocatalysts for solar energy conversion and synthetic organic chemistry. They luminesce from redox-active excited states that can have high triplet energies and long lifetimes, making them well suited for energy transfer and photoredox catalysis. Homoleptic tris(cyclometalated) iridium(III) complexes are typically very hydrophobic and do not dissolve well in polar solvents, somewhat limiting their application scope. We developed a family of water-soluble sulfonate-decorated variants with tailored redox potentials and excited-state energies to address several key challenges in aqueous photochemistry.First, we aimed at combining enzyme with photoredox catalysis to synthesize enantioenriched products in a cyclic reaction network. Since the employed biocatalyst operates best in aqueous solution, a water-soluble photocatalyst was needed. A new tris(cyclometalated) iridium(III) complex provided enough reducing power for the photochemical reduction of imines to racemic mixtures of amines and furthermore was compatible with monoamine oxidase (MAO-N-9), which deracemized this mixture through a kinetic resolution of the racemic amine via oxidation to the corresponding imine. This process led to the accumulation of the unreactive amine enantiomer over time. In subsequent studies, we discovered that the same iridium(III) complex photoionizes under intense irradiation to give hydrated electrons as a result of consecutive two-photon excitation. With visible light as energy input, hydrated electrons become available in a catalytic fashion, thereby allowing the comparatively mild reduction of substrates that would typically only be reactive under harsher conditions. Finally, we became interested in photochemical upconversion in aqueous solution, for which it was desirable to obtain water-soluble iridium(III) compounds with very high triplet excited-state energies. This goal was achieved through improved ligand design and ultimately enabled sensitized triplet-triplet annihilation upconversion unusually far into the ultraviolet spectral range.Studies of photoredox catalysis, energy transfer catalysis, and photochemical upconversion typically rely on the use of organic solvents. Water could potentially be an attractive alternative in many cases, but photocatalyst development lags somewhat behind for aqueous solution compared to organic solvent. The purpose of this Account is to provide an overview of the breadth of new research perspectives that emerged from the development of water-soluble

Indexed as

IridiumOrganometallic CompoundsAminesElectronsEnergy TransferLigandsPhotochemistrySolventsWaterAminesIridiumLigandsOrganometallic CompoundsSolventsWater

Identifiers

PMID35414170
PMCPMC9069695
OpenAlexW4223474210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.